LSVT Global receives ARTG Certificate from Australian Government for the LSVT Companion
LSVT Global, Inc. is proud to announce that they have received the Australian Register of Therapeutic Goods (ARTG) Certificate from the Department of Health and Ageing, Therapeutic Goods Administration of the Australian Government for the LSVT Companion treatment system for speech disorders associated with Parkinson disease and other neurological disorders.
(NYC, New York) LSVT Global, Inc. is proud to announce that they have received the ARTG Certificate from the Department of Health and Ageing, Therapeutic Goods Administration of the Australian Government for the LSVT Companion treatment system for speech disorders associated with Parkinson disease and other neurological disorders. This allows availability in Australia of the eagerly awaited Companion Clinician and Home editions to LSVT LOUD certified clinicians and their clients. Both versions of this highly acclaimed treatment system can now be purchased online in Australia. This Australian certification follows earlier FDA clearance and EU CE registration of the Companion.
The LSVT Companion is a software aid to clinicians providing LSVT LOUD treatments. The Home edition allows clients to practice the treatment independently while being monitored by their clinician. LSVT LOUD speech treatment is the only protocol to be clinically proven to improve communication in people with Parkinson disease and other neurological movement disorders. Over 6,000 speech-language pathologists worldwide have been trained and certified by LSVT Global to provide this treatment.
Using the LSVT Companion, clients interact with dynamic software as they move through the well established and highly efficacious LSVT LOUD treatment. The Companion guides and tracks a client’s speech performance and allows for direct long-term client use outside of the clinical setting, significantly expanding clinician impact and reducing time and cost.
About LSVT Global. LSVT Global provides innovative speech and whole body treatments to improve the quality of life of adults and children with neurological disorders, such as Parkinson disease, multiple sclerosis, stroke and cerebral palsy by enabling them to communicate and move more effectively. LSVT Global’s business is founded on two main pillars. The company offers clinical training to health care practitioners around the world and delivers treatments via Telemedicine and other technological applications.
For additional information and to purchase the LSVT Companion visit http://lsvtglobal.serverbeta.com/products/category/software
For business development and investor relations please contact: Mr. Shinneman at FShinneman@lsvtglobal.com Tel.: (908) 305-4986.